38
In band
Moving averages
SMA 200$1.10-21.73%
Company profile
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$15.14M
P/E ratioNone
EPS$-0.64
Beta0.616
Dividend yield0.00%
52-week high$1.58
52-week low$0.75
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
KTTA
Pasithea Therapeutics Corp
RSI 34
PHIO
Phio Pharmaceuticals Corp
RSI 37
BYSI
BeyondSpring Inc
RSI 54
SNGX
Soligenix Inc
RSI 48
ACXP
Acurx Pharmaceuticals Inc
RSI 27
BCTX
BriaCell Therapeutics Corp - New
RSI 31
RSI alerts for BCDA
An email when BCDA closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:01 PM EDT